COVID-19 vaccine was approved for use among minors aged 5 to 11 in South Korea.
According to South Korea’s Food and Drug safety agency the two-dose vaccine, developed by Pfizer and BioNTech was approved for use among minors aged 5 to 11, with a lower dose level of 10 micrograms.
The children will receive two doses of the vaccine at a three-week interval. It is also said that Immunity compromised children can get a booster shot four weeks later.
The health authorities planned to announce a detailed schedule for the vaccination of the children next month.
The authorization was aimed at helping prevent the infections and the hospitalizations of the children amid the spread of the Omicron variant.
